Gastric lymphoma: The histology report

Digestive and Liver Disease

Volumn 43, Issue SUPPL. 4, 2011, Pages

  Doglioni, Claudio ^a,b   Ponzoni, Maurilio ^a   Ferreri, Andrés J M ^a   Savio, Antonella ^c,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c ST MARK S HOSPITAL   (United Kingdom)

^d Fondazione Poliambulanza   (Italy)

Author keywords

Extranodal marginal zone lymphoma; Gastric MALT lymphoma; GIPAD report; Helicobacter pylori

Indexed keywords

ANTIBIOTIC AGENT;

ABDOMINAL MASS; ANTIMICROBIAL THERAPY; ARTICLE; CANCER STAGING; ENDOSCOPIC ECHOGRAPHY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GASTROSCOPY; HELICOBACTER INFECTION; HEMATEMESIS; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; INFLAMMATORY INFILTRATE; LARGE CELL LYMPHOMA; LYMPH FOLLICLE; LYMPHOCYTIC INFILTRATION; MELENA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NAUSEA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; STOMACH BIOPSY; STOMACH LYMPHOMA; STOMACH PAIN; UREA BREATH TEST; VOMITING;

ANTI-BACTERIAL AGENTS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; GASTRIC MUCOSA; GASTROSCOPY; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; NEOPLASM STAGING; PATHOLOGY; RECURRENCE; REMISSION INDUCTION; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 79953173595     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(11)60587-2     Document Type: Article

References (41)

1. Hussell T, Isaacson PG, Crabtree JE, et al. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993, 342:571-574.
2. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993, 342:575-577.
3. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994, 330:1267-1271.
4. Doglioni C, Wotherspoon AC, Moschini A, et al. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992, 339:834-835.
5. Luminari S, Cesaretti M, Marcheselli, et al. Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas. Ann Oncol 2010, 21:855-859.
6. Wotherspoon AC, Doglioni C, Isaacson PG Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology 1992, 20:29-34.
7. Du MQ, Diss TC, Dogan A, et al. Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosa. J Pathol 2000, 192:488-493.
8. Chan JK, Ng CS, Isaacson PG Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 1990, 136:1153-1164.
9. van Krieken JH, Langerak AW, Macintyre EA, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 2007, 21:201-206.
10. Hummel M, Oeschger S, Barth TF, et al. Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritis. Gut 2006, 55:782-787.
11. Dierlamm J, Baens M, Wlodarska I The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999, 93:3601-3609.
12. Liu H, Ye H, Dogan A, et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001, 98:1182-1187.
13. Liu H, Ye H, Ruskone-Fourmestraux A, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002, 122:1286-1294.
14. Huang X, Zhang Z, Liu H, et al. t(11;18)(q21;q21) in gastric MALT lymphoma and diffuse large B-cell lymphoma of Chinese patients. Hematol J 2003, 4:342-345.
15. Nakamura S, Matsumoto T, Ye, et al. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment. Cancer 2006, 107:2770-2778.
16. Raderer M, Streubel B, Wöhrer S Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut 2006, 55:616-618.
17. Kawamoto K, Nakamura S, Iwashita A, et al. Clinicopathological characteristics of primary gastric T-cell lymphoma. Histopathology 2009, 55:641-653.
18. Swerdlow SH, Campo E, Harris NL, et al. The World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, WHO, Lyon.
19. de Jong D, Boot H, van Heerde P, et al. Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 1997, 112:1466-1474.
20. Chen LT, Lin JT, Tai JJ, et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst 2005, 97:1345-1353.
21. Sandmeier D, Benhattar J, Bouzourene H The natural history of a gastric low grade B cell MALT lymphoma followed during 11 years without treatment. J Clin Pathol 2002, 55:548-550.
22. Zucca E, Dreyling M, ESMO Guidelines Working Group Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20(Suppl 4):113-114.
23. Sackmann M, Morgner A, Rudolph B, et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 1997, 113:108.
24. Nakamura S, Matsumoto T, Suekane H, et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut 2001, 48:454-460.
25. Levy M, Copie-Bergman C, Traulle C, Groupe d'Etude des Lymphomes de l'Adulte (GELA), et al. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol 2002, 97:292-297.
26. Caletti G, Ferrari A, Brocchi E, et al. Accuracy of endoscopic ultra-sonography in the diagnosis and staging of gastric cancer and lymphoma. Surgery 1993, 113:14-27.
27. Raderer M, Wöhrer S, Streubel B, et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 2006, 24:3136-3141.
28. Ruskone-Fourmestraux A, Fischbach W, Aleman BMP, on behalf of the EGILS Group. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 2011; in press. [Epub ahead of print doi:10.1136/gut.2010.224949].
29. Ruskoné-Fourmestraux A, Dragosics B, Morgner A, et al. Paris staging system for primary gastrointestinal lymphomas. Gut 2003, 52:912-913.
30. Baumgaertner I, Copie-Bergman C, Levy M, et al. Complete remission of gastric Burkitt's lymphoma after eradication of Helicobacter pylori. World J Gastroenterol 2009, 15:5746-5750.
31. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007, 56:772-781.
32. Janssen J The impact of EUS in primary gastric lymphoma. Best Pract Res Clin Gastroenterol 2009, 23:671-678.
33. Copie-Bergman C, Gaulard P, Lavergne-Slove A, et al. Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 2003, 52:1656.
34. Shiozawa E, Norose T, Kaneko K, et al. Clinicopathological comparison of the World Health Organization/Wotherspoon score to the Groupe d'Etude des Lymphomes de l'Adult grade for the post-treatment evaluation of gastric mucosa-associated lymphoid tissue lymphoma. J Gastroenterol Hepatol 2009, 24:307-315.
35. Zullo A, Hassan C, Cristofari F, et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 2010, 8:105-110.
36. Lévy M, Copie-Bergman C, Gameiro C, et al. Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol 2005, 23:5061-5066.
37. Savio A, Zamboni G, Capelli P, et al. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. Recent Results Cancer Res 2000, 156:116-124.
38. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, EGILS (European Gastro-Intestinal Lymphoma Study) Group, et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 2007, 6:1685-1687.
39. Andriani A, Miedico A, Tedeschi L, et al. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. Dig Liver Dis 2009, 41:467-473.
40. Stathis A, Chini C, Bertoni F, et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol 2009, 20:1086-1093.
41. Capelle LG, de Vries AC, Looman CW, et al. Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 2008, 44:2470-2476.